| [1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
|
| [2] |
Ikai I, Arii S, Okazaki M, et al. Report of the 17th nationwide follow-up survey of primary liver cancer in Japan[J]. Hepatol Res, 2007, 37(9): 676-691. DOI: 10.1111/j.1872-034X.2007.00119.x.
|
| [3] |
Roy S, Banerjee P, Ekser B, et al. Targeting lymphangiogenesis and lymph node metastasis in liver cancer[J]. Am J Pathol, 2021, 191(12): 2052-2063. DOI: 10.1016/j.ajpath.2021.08.011.
|
| [4] |
Sun HC, Zhuang PY, Qin LX, et al. Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy[J]. J Surg Oncol, 2007, 96(1): 37-45. DOI: 10.1002/jso.20772.
|
| [5] |
Park YJ, Lim DH, Paik SW, et al. Radiation therapy for abdominal lymph node metastasis from hepatocellular carcinoma[J]. J Gastroenterol, 2006, 41(11): 1099-1106. DOI: 10.1007/s00535-006-1895-x.
|
| [6] |
Schwartz JD, Beutler AS. Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma[J]. Anticancer Drugs, 2004, 15(5): 439-452. DOI: 10.1097/01.cad.0000131140.12228.bb.
|
| [7] |
|
| [8] |
Changchien CS, Chen CL, Yen YH, et al. Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival[J]. J Gastroenterol, 2008, 43(2): 159-170. DOI: 10.1007/s00535-007-2134-9.
|
| [9] |
Lee CW, Chan KM, Lee CF, et al. Hepatic resection for hepatocellular carcinoma with lymph node metastasis: clinicopathological analysis and survival outcome[J]. Asian J Surg, 2011, 34(2): 53-62. DOI: 10.1016/S1015-9584(11)60020-1.
|
| [10] |
Zeng ZC, Tang ZY, Fan J, et al. Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients[J]. Int J Radiat Oncol Biol Phys, 2005, 63(4): 1067-1076. DOI: 10.1016/j.ijrobp.2005.03.058.
|
| [11] |
Ercolani G, Grazi GL, Ravaioli M, et al. The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy[J]. Ann Surg, 2004, 239(2): 202-209. DOI: 10.1097/01.sla.0000109154.00020.e0.
|
| [12] |
Shen X, Li H, Wang F, et al. Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma[J]. World J Surg, 2010, 34(5): 1028-1033. DOI: 10.1007/s00268-010-0400-0.
|
| [13] |
|
| [14] |
Kobayashi S, Takahashi S, Kato Y, et al. Surgical treatment of lymph node metastases from hepatocellular carcinoma[J]. J Hepatobiliary Pancreat Sci, 2011, 18(4): 559-566. DOI: 10.1007/s00534-011-0372-y.
|
| [15] |
|
| [16] |
|
| [17] |
Tomimaru Y, Wada H, Eguchi H, et al. Clinical significance of surgical resection of metastatic lymph nodes from hepatocellular carcinoma[J]. Surg Today, 2015, 45(9): 1112-1120. DOI: 10.1007/s00595-014-1028-8.
|
| [18] |
|
| [19] |
CSCO胆道肿瘤专家委员会. CSCO胆道系统肿瘤诊断治疗专家共识(2019年版)[J]. 临床肿瘤学杂志, 2019, 24(9): 828-838.
|
| [20] |
|
| [21] |
|
| [22] |
Ravaioli M, Ercolani G, Grazi GL, et al. Safety and prognostic role of regional lymphadenectomy for primary and metastatic liver tumors[J]. Updates Surg, 2010, 62(1): 27-34. DOI: 10.1007/s13304-010-0008-9.
|
| [23] |
|
| [24] |
Kim K, Chie EK, Kim W, et al. Absence of symptom and intact liver function are positive prognosticators for patients undergoing radiotherapy for lymph node metastasis from hepatocellular carcinoma[J]. Int J Radiat Oncol Biol Phys, 2010, 78(3): 729-734. DOI: 10.1016/j.ijrobp.2009.08.047.
|
| [25] |
Lee BM, Choi JY, Seong J. Efficacy of local treatment in lymph node metastasis from hepatocellular carcinoma[J]. Liver Cancer, 2023, 12(3): 218-228. DOI: 10.1159/000529201.
|
| [26] |
|
| [27] |
|
| [28] |
刘国锟, 郭艳霞. 索拉菲尼治疗晚期肝癌患者的临床疗效和安全性分析[J]. 中国处方药, 2020, 18(7): 77-78.
|
| [29] |
|